Equity ETF Channel Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause By Ian YoungApril 13, 2021
Nasdaq Investment Intelligence Channel Why Small Cap Biotech ETFs Are Still Brilliant Bets By Tom LydonMarch 26, 2021
Innovative ETFs Channel Greater Regulatory Scrutiny Could Weigh on Biotech ETFs By Max ChenMarch 24, 2021
Disruptive Technology Channel The Latest in Fintech ETFs? Melding Supply and Demand By Tom LydonFebruary 25, 2021
Innovative ETFs Channel Illumina Earnings, Forward Guidance Strengthen Biotech ETFs By Max ChenFebruary 12, 2021
Innovative ETFs Channel Tech ETFs Were the Biggest Losers of the Georgia Runoff By Max ChenJanuary 6, 2021
Featured Moderna Helps Biotech ETFs Mitigate Massive Losses as Stocks Tumble By Ian YoungJanuary 4, 2021
Innovative ETFs Channel Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021 By Max ChenDecember 31, 2020
Featured As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally By Ian YoungDecember 3, 2020
Disruptive Technology Channel Bitcoin and Square Teaming Up to Supercharge Fintech ETFs By Tom LydonNovember 23, 2020